Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ATEC 
Alphatec Holdings Inc (ATEC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: ATEC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $20.96
1 Year Target Price $20.96
| 4 | Strong Buy |
| 5 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 22.71% | Avg. Invested days 31 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.90B USD | Price to earnings Ratio - | 1Y Target Price 20.96 |
Price to earnings Ratio - | 1Y Target Price 20.96 | ||
Volume (30-day avg) 10 | Beta 1.1 | 52 Weeks Range 8.18 - 20.15 | Updated Date 11/6/2025 |
52 Weeks Range 8.18 - 20.15 | Updated Date 11/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When - | Estimate -0.033 | Actual 0.03 |
Profitability
Profit Margin -21.29% | Operating Margin (TTM) -4.79% |
Management Effectiveness
Return on Assets (TTM) -6% | Return on Equity (TTM) -540.41% |
Valuation
Trailing PE - | Forward PE 30.58 | Enterprise Value 2465822744 | Price to Sales(TTM) 3.98 |
Enterprise Value 2465822744 | Price to Sales(TTM) 3.98 | ||
Enterprise Value to Revenue 3.61 | Enterprise Value to EBITDA -18.89 | Shares Outstanding 148550185 | Shares Floating 117332364 |
Shares Outstanding 148550185 | Shares Floating 117332364 | ||
Percent Insiders 20.44 | Percent Institutions 69.44 |
Upturn AI SWOT
Alphatec Holdings Inc
Company Overview
History and Background
Alphatec Holdings, Inc. was founded in 2006. It focuses on designing, developing, and marketing spinal surgery solutions. The company has evolved through organic growth and strategic acquisitions, expanding its product portfolio and market reach.
Core Business Areas
- Spinal Implants: Designs, develops, and markets a range of implants for spinal fusion and other surgical procedures.
- Biologics: Offers biologic products to promote bone growth and healing in spinal procedures.
- Surgical Access Systems: Provides instruments and systems for accessing the spine during surgery.
- Navigation and Robotics: Develops and markets advanced navigation and robotic systems for spinal surgery, including its AlphaInformatiX platform.
Leadership and Structure
Patrick S. Miles is the Chairman and CEO. The organizational structure includes departments for research and development, sales and marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- Aurora Spine System: Posterior Fixation System. Competitors include Medtronic, Stryker and Johnson & Johnson. No direct market share revenue figures publicly available but drives a significant portion of spinal implants revenue.
- IdentiTi Porous TI Technology: A line of porous titanium implants for interbody fusion. Competitors include Medtronic, Stryker and Johnson & Johnson.No direct market share revenue figures publicly available but drives a significant portion of spinal implants revenue.
- AlphaInformatiX: A comprehensive surgical navigation and robotics platform. No direct market share revenue figures publicly available. Competitors include Medtronic's Mazor X Stealth Edition and Globus Medical's ExcelsiusGPS.
Market Dynamics
Industry Overview
The spinal surgery market is driven by an aging population, increasing incidence of spinal disorders, and technological advancements. Growth is fueled by minimally invasive techniques and robotic-assisted surgery.
Positioning
Alphatec is positioning itself as a technology leader in the spinal surgery market through its focus on advanced navigation and robotics. It competes with larger, more established players.
Total Addressable Market (TAM)
The global spinal implants and surgical devices market is estimated at $10-12 billion. Alphatec aims to increase its market share through product innovation and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Innovative product portfolio
- Focus on advanced technology (navigation and robotics)
- Strong relationships with surgeons
- Rapid revenue growth
Weaknesses
- Smaller market share compared to larger competitors
- Reliance on product innovation for growth
- Profitability not yet established
- High operating expenses relative to revenue
Opportunities
- Expanding into new geographic markets
- Acquiring complementary technologies or businesses
- Increasing adoption of navigation and robotics in spinal surgery
- Partnerships with hospitals and surgery centers
Threats
- Intense competition from larger players
- Pricing pressures and reimbursement challenges
- Product liability risks
- Economic downturn affecting elective surgery volumes
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- GBLT
- SIFI
Competitive Landscape
Alphatec differentiates itself through technological innovation but faces intense competition from companies with greater financial resources and established market presence.
Major Acquisitions
EOS imaging
- Year: 2020
- Acquisition Price (USD millions): 119.6
- Strategic Rationale: Enhanced imaging and surgical planning capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been strong, driven by product launches and market penetration.
Future Projections: Analysts project continued revenue growth, driven by adoption of its technology platform. Profitability is expected to improve as the company scales.
Recent Initiatives: Recent initiatives include the launch of new navigation and robotic technologies, strategic acquisitions, and expansion of the sales force.
Summary
Alphatec Holdings is an innovative spinal surgery company with strong revenue growth, driven by its advanced technology. However, it faces challenges related to profitability, competition, and financial risk. The company needs to manage expenses and execute its growth strategy effectively to achieve long-term success. Continued innovation and strategic partnerships are vital for maintaining its competitive edge.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Investor Presentations
- Analyst Reports
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alphatec Holdings Inc
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 2006-06-02 | Executive Chairman, CEO & President Mr. Patrick S. Miles | ||
Sector Healthcare | Industry Medical Devices | Full time employees 867 | Website https://www.atecspine.com |
Full time employees 867 | Website https://www.atecspine.com | ||
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.